Molecular imaging in drug discovery and development

被引：623

作者：

Rudin, M

Weissleder, R ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland

[2] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA 02129 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2003年 / 2卷 / 02期

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1038/nrd1007

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Imaging sciences have grown exponentially during the past three decades, and many techniques, such as magnetic resonance imaging, nuclear tomographic imaging and X-ray computed tomography, have become indispensable in clinical use. Advances in imaging technologies and imaging probes for humans and for small animals are now extending the applications of imaging further into drug discovery and development, and have the potential to considerably accelerate the process. This review summarizes some of the recent developments in conventional and molecular imaging, and highlights their impact on drug discovery.

引用

收藏

页码：123 / 131

页数：9

相关论文

共 83 条

[1] Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients [J].

Aboagye, EO ;

Luthra, SK ;

Brady, F ;

Poole, K ;

Anderson, H ;

Jones, T ;

Boobis, A ;

Burtles, SS .

BRITISH JOURNAL OF CANCER, 2002, 86 (07) :1052-1056

[2] Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands [J].

Becker, A ;

Hessenius, C ;

Licha, K ;

Ebert, B ;

Sukowski, U ;

Semmler, W ;

Wiedenmann, B ;

Grötzinger, C .

NATURE BIOTECHNOLOGY, 2001, 19 (04) :327-331

[3] From anatomy to the target: Contributions of magnetic resonance imaging to preclinical pharmaceutical research [J].

Beckmann, N ;

Mueggler, T ;

Allegrini, PR ;

Laurent, D ;

Rudin, M .

ANATOMICAL RECORD, 2001, 265 (02) :85-100

[4] Optical imaging of Renilla luciferase reporter gene expression in living mice [J].

Bhaumik, S ;

Gambhir, SS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :377-382

[5]

Bhujwalla Z M, 2001, Novartis Found Symp, V240, P23

[6] Fluorescent tissue site-selective lanthanide chelate, Tb-PCTMB for enhanced imaging of cancer [J].

Bornhop, DJ ;

Hubbard, DS ;

Houlne, MP ;

Adair, C ;

Kiefer, GE ;

Pence, BC ;

Morgan, DL .

ANALYTICAL CHEMISTRY, 1999, 71 (14) :2607-2615

[7] Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET [J].

Brady, F ;

Luthra, SK ;

Brown, GD ;

Osman, S ;

Aboagye, E ;

Saleem, A ;

Price, PM .

CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (18) :1863-1892

[8] In vivo molecular target assessment of matrix metalloproteinase inhibition [J].

Bremer, C ;

Tung, CH ;

Weissleder, R .

NATURE MEDICINE, 2001, 7 (06) :743-748

[9] In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy [J].

Brown, EB ;

Campbell, RB ;

Tsuzuki, Y ;

Xu, L ;

Carmeliet, P ;

Fukumura, D ;

Jain, RK .

NATURE MEDICINE, 2001, 7 (07) :864-868

[10] Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform [J].

Bugaj, JE ;

Achilefu, S ;

Dorshow, RB ;

Rajagopalan, R .

JOURNAL OF BIOMEDICAL OPTICS, 2001, 6 (02) :122-133

← 1 2 3 4 5 6 7 8 9 →